Ombuds
Food and Drug Administration, Center for Drug Evaluation and Research
Virginia L. Behr
Ombudsman, Center for Drug Evaluation and Research (CDER)
Food and Drug Administration
U.S. Department of Health and Human Services
As the CDER Ombudsman since 2007, Virginia addresses questions and complaints from CDER-regulated industry and informally resolves disputes between those entities and CDER. She is an active Coalition of Federal Ombudsman member; she currently chairs the Mentoring Committee and served on its Executive Committee for three years. She mediates cases as a collateral duty for the federal government-wide Shared Neutrals program and FDA’s Conflict Prevention and Resolution Program.
After a brief research position at the NIH and USUHS, Virginia started her FDA career as a regulatory project manager in CDER's Division of Antiviral Products in 1999, later becoming its Chief of Project Management Staff. She provided regulatory expertise for multi-disciplinary teams and supervised the management of Investigational New Drug Applications (IND), Biologic Licensing Applications (BLA), and New Drug Applications (NDA) for the treatment and/or prevention of HIV/AIDS, herpes, influenza, hepatitis, and other viruses.
Virginia earned her B.S. degree in psychology from Washington and Lee University. When off duty, Virginia explores new places near and far with her family, kayaks, flexes her creative side in the kitchen, and plays competitive volleyball.
Disclosure information not submitted.
Tuesday, September 13, 2022
3:30 PM – 4:30 PM MST